Hydrogen-rich Water for Mucositis
Trial Summary
What is the purpose of this trial?
This trial investigates if drinking hydrogen-rich water can help head and neck cancer patients who have painful mouth sores from radiation therapy by reducing inflammation and pain.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
How is hydrogen-rich water different from other treatments for mucositis?
Hydrogen-rich water is unique because it acts as a potent antioxidant and anti-inflammatory agent, which may help protect and heal tissues by reducing oxidative stress and inflammation. Unlike other treatments, it is administered by drinking water infused with molecular hydrogen, making it a practical and non-invasive option.12345
Research Team
Kartik Mani, MD
Principal Investigator
Stony Brook University
Eligibility Criteria
This trial is for individuals with head and neck cancer, who are about to undergo daily radiotherapy for more than 4 weeks. Participants must be able to give consent, have a Karnofsky Performance Score of at least 70, swallow normally, and describe their pain.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Radiation
Participants undergo radiation therapy for head and neck cancer
Treatment
Participants receive hydrogen-rich water to mitigate acute mucositis during radiation therapy
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Hydrogen tablets
Find a Clinic Near You
Who Is Running the Clinical Trial?
Clare Moran
Lead Sponsor
Stony Brook University
Lead Sponsor
DrinkHRW
Collaborator